Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence.
Despite the demonstration that chronic morphine increases phosphorylation of multiple substrate proteins, their identity has, for the most part, remained elusive. Thus far, chronic morphine has not been shown to increase the phosphorylation of any identified effector protein. This is the first demonstration that persistent activation of opioid receptors has profound effects on phosphorylation of adenylyl cyclase (AC). A dramatic increase in phosphorylation of AC (type II family) was observed in ileum longitudinal muscle myenteric plexus preparations obtained from chronic morphine-treated guinea pigs. Analogous results were obtained when AC was immunoprecipitated using two differentially directed AC antibodies. The magnitude of the augmented AC phosphorylation was substantially attenuated by chelerythrine, a protein kinase C-selective inhibitor. These results suggest the potential relevance of increased phosphorylation (protein kinase C-mediated) of AC to opioid tolerant/dependent mechanisms. Because phosphorylation of AC isoforms (type II family) can significantly increase their stimulatory responsiveness to Gsalpha and Gbetagamma, this mechanism could underlie, in part, the predominance of opioid AC stimulatory signaling observed in opioid tolerant/dependent tissue. Moreover, in light of the fact that many G protein-coupled receptors signal through common effector proteins, this effect provides a mechanism for divergent consequences of chronic morphine treatment and could explain the well documented complexity of changes that accompany the opioid tolerant/dependent state.
Chakrabarti
S
S
Department of Biochemistry, State University of New York, Health Science Center at Brooklyn, Brooklyn, New York 11203, USA.
Wang
L
L
Tang
W J
WJ
Gintzler
A R
AR
D000262:Adenylyl Cyclases / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D004343:Drug Implants; D004361:Drug Tolerance; D006168:Guinea Pigs; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects* / Q000201:enzymology / Q000294:innervation; D009197:Myenteric Plexus / Q000187:drug effects* / Q000201:enzymology; D009293:Opioid-Related Disorders / Q000201:enzymology*; D010761:Phosphorus Radioisotopes; D010766:Phosphorylation; D011233:Precipitin Tests; D015398:Signal Transduction; D015854:Up-Regulation
D004343:Drug Implants; D010761:Phosphorus Radioisotopes; D009020:Morphine; D000262:Adenylyl Cyclases